Metabolites of neuroinflammation relate to neuropathic pain after spinal cord injury
Authors:
- Dario PfyfferDPDario Pfyffer
- Patrik O. WyssPWPatrik O. Wyss
- Eveline HuberEHEveline Huber
- Armin CurtACArmin Curt
- Anke HenningAHAnke Henning
- Patrick FreundPFPatrick Freund
Open Access
- 18 August 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 95 (7) , e805-e814
Abstract
Objective To determine whether cervical cord levels of metabolites are associated with pain sensation after spinal cord injury (SCI) by performing magnetic resonance spectroscopy in patients with SCI with and without neuropathic pain (NP). Methods Cervical cord single-voxel spectroscopic data of 24 patients with SCI (14 with NP, 10 pain-free) and 21 healthy controls were acquired at C2/3 to investigate metabolite ratios associated with neuroinflammation (choline-containing compounds to myoinositol [tCho/mI]) and neurodegeneration (total N-acetylaspartate to myo-inositol [tNAA/mI]). NP levels were measured, and Spearman correlation tests assessed associations between metabolite levels, cord atrophy, and pinprick score. Results In patients with NP, tCho/mI levels were increased (p = 0.024) compared to pain-free patients and negatively related to cord atrophy (p = 0.006, r = 0.714). Better pinprick score was associated with higher tCho/mI levels (p = 0.032, r = 0.574). In pain-free patients, tCho/mI levels were not related to cord atrophy (p = 0.881, r = 0.055) or pinprick score (p = 0.676, r = 0.152). tNAA/mI levels were similar in both patient groups (p = 0.396) and were not associated with pinprick score in patients with NP (p = 0.405, r = 0.242) and pain-free patients (p = 0.117, r = 0.527). Conclusions Neuroinflammatory metabolite levels (i.e., tCho/mI) were elevated in patients with NP, its magnitude being associated with less cord atrophy and greater pain sensation (e.g., pinprick score). This suggests that patients with NP have more residual spinal tissue and greater metabolite turnover than pain-free patients. Neurodegenerative metabolite levels (i.e., tNAA/mI) were associated with greater cord atrophy but unrelated to NP. Identifying the metabolic NP signature provides new NP treatment targets and could improve patient stratification in interventional trials. Classification of evidence This study provides Class II evidence that levels of magnetic resonance spectroscopy–identified metabolites of neuroinflammation were elevated in patients with SCI with NP compared to those without NP.Keywords
This publication has 46 references indexed in Scilit:
- MRI investigation of the sensorimotor cortex and the corticospinal tract after acute spinal cord injury: a prospective longitudinal studyThe Lancet Neurology, 2013
- Metabolite concentrations in the anterior cingulate cortex predict high neuropathic pain impact after spinal cord injuryPain, 2013
- 1H-MR Spectroscopy in the Human Spinal CordAmerican Journal of Neuroradiology, 2012
- Spatial and temporal activation of spinal glial cells: Role of gliopathy in central neuropathic pain following spinal cord injury in ratsExperimental Neurology, 2012
- Alteration of Forebrain Neurogenesis after Cervical Spinal Cord Injury in the Adult RatFrontiers in Neuroscience, 2012
- International standards for neurological classification of spinal cord injury (Revised 2011)The Journal of Spinal Cord Medicine, 2011
- Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: Application in multiple sclerosisNeuroImage, 2010
- Residual spinothalamic tract pathways predict development of central pain after spinal cord injuryBrain, 2008
- Optimized detection of lactate at high fields using inner volume saturationMagnetic Resonance in Medicine, 2006
- Estimation of metabolite concentrations from localized in vivo proton NMR spectraMagnetic Resonance in Medicine, 1993